HK1021861A1 - A method of using eukaryotic expression vectors comprising the bk virus enhancer. - Google Patents

A method of using eukaryotic expression vectors comprising the bk virus enhancer.

Info

Publication number
HK1021861A1
HK1021861A1 HK99105677A HK99105677A HK1021861A1 HK 1021861 A1 HK1021861 A1 HK 1021861A1 HK 99105677 A HK99105677 A HK 99105677A HK 99105677 A HK99105677 A HK 99105677A HK 1021861 A1 HK1021861 A1 HK 1021861A1
Authority
HK
Hong Kong
Prior art keywords
expression vectors
eukaryotic expression
virus enhancer
enhancer
virus
Prior art date
Application number
HK99105677A
Other languages
English (en)
Inventor
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HK1021861A1 publication Critical patent/HK1021861A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/30—Vector systems having a special element relevant for transcription being an enhancer not forming part of the promoter region
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK99105677A 1986-04-09 1998-08-26 A method of using eukaryotic expression vectors comprising the bk virus enhancer. HK1021861A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84999986A 1986-04-09 1986-04-09
HK98110236A HK1009605A1 (en) 1986-04-09 1998-08-26 A method of using eukaryotic expression vectors comprising the bk virus enhancer

Publications (1)

Publication Number Publication Date
HK1021861A1 true HK1021861A1 (en) 2000-07-07

Family

ID=25307027

Family Applications (2)

Application Number Title Priority Date Filing Date
HK99105677A HK1021861A1 (en) 1986-04-09 1998-08-26 A method of using eukaryotic expression vectors comprising the bk virus enhancer.
HK98110236A HK1009605A1 (en) 1986-04-09 1998-08-26 A method of using eukaryotic expression vectors comprising the bk virus enhancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK98110236A HK1009605A1 (en) 1986-04-09 1998-08-26 A method of using eukaryotic expression vectors comprising the bk virus enhancer

Country Status (11)

Country Link
EP (3) EP0576049A1 (fr)
JP (5) JP3162056B2 (fr)
AU (1) AU605479B2 (fr)
CA (2) CA1340384C (fr)
DE (3) DE3752382T2 (fr)
DK (1) DK176387A (fr)
ES (3) ES2237755T3 (fr)
HK (2) HK1021861A1 (fr)
HU (1) HU211391B (fr)
IE (3) IE81065B1 (fr)
IL (5) IL98886A (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613481D0 (en) * 1986-06-04 1986-07-09 Diatech Ltd Translation of mrna
EP3020808B1 (fr) * 2013-07-11 2019-09-11 Takara Bio Inc. Procédé de fabrication de virus associé à adéno
EP3105311A1 (fr) 2014-02-10 2016-12-21 Univercells NV Système, appareil et procédé de production de biomolécules
EP3168298B1 (fr) 2014-07-10 2019-04-17 Takara Bio Inc. Procédé de fabrication de particules de virus sans enveloppe
CN107109374B (zh) 2015-01-09 2021-04-06 宝生物工程株式会社 用于生产无包膜病毒颗粒的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8327860D0 (en) * 1983-10-18 1983-11-16 Fujisawa Pharmaceutical Co Monoclonal antiprotein c antibody
JPH0789930B2 (ja) * 1984-03-08 1995-10-04 大正製薬株式会社 ウイルス性転写促進配列
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
JPH02502605A (ja) * 1987-03-13 1990-08-23 シェリング・コーポレーション 遺伝子発現の刺激方法
JPH0660120A (ja) * 1992-08-06 1994-03-04 Sharp Corp 可変長データの格納方法及び検索装置

Also Published As

Publication number Publication date
DK176387D0 (da) 1987-04-07
IL82093A0 (en) 1987-10-30
EP0699764B1 (fr) 2005-03-09
ES2237755T3 (es) 2005-08-01
IL98887A (en) 1992-12-01
HK1009605A1 (en) 1999-06-04
ES2107997T3 (es) 1997-12-16
JP3162056B2 (ja) 2001-04-25
AU605479B2 (en) 1991-01-17
EP0584845A1 (fr) 1994-03-02
DK176387A (da) 1987-11-13
CA1318619C (fr) 1993-06-01
IL82093A (en) 1992-12-01
DE3752134T2 (de) 1998-03-19
DE3752382D1 (de) 2005-04-14
CA1340384C (fr) 1999-02-09
JP2877228B2 (ja) 1999-03-31
IE870912L (en) 1987-10-09
JPH099980A (ja) 1997-01-14
HUT43633A (en) 1987-11-30
IL98886A0 (en) 1992-07-15
JPS6312296A (ja) 1988-01-19
JPH1057081A (ja) 1998-03-03
DE3752382T2 (de) 2005-12-29
IE980257A1 (en) 1987-10-09
EP0699764A1 (fr) 1996-03-06
EP0584845B1 (fr) 2004-09-08
EP0576049A1 (fr) 1993-12-29
ES2227514T3 (es) 2005-04-01
IE81065B1 (en) 2000-01-12
JPH11346789A (ja) 1999-12-21
AU7117587A (en) 1987-10-15
DE3752376D1 (de) 2004-10-14
JP2001145496A (ja) 2001-05-29
DE3752134D1 (de) 1997-12-04
JP2958286B2 (ja) 1999-10-06
IL98887A0 (en) 1992-07-15
IL98886A (en) 1992-12-01
HU211391B (en) 1995-11-28
IE980258A1 (en) 1987-10-09

Similar Documents

Publication Publication Date Title
AU592236B2 (en) Amplitude-adapted vector quantizer
CS301187A2 (en) Microemulsion
DE3888381D1 (de) Hefevektor.
DE68923227D1 (de) Vektor-zu-Raster-Umwandlungsverfahren.
AU573130B2 (en) 1,3,4-triazole sulphonamides
AU7312787A (en) Improved tandem-axle walking beam suspension
GB8700857D0 (en) Underpinning unstable structures
DE3685955D1 (en) Biosynthese von heteropolysacchariden.
HK1021861A1 (en) A method of using eukaryotic expression vectors comprising the bk virus enhancer.
ZA879118B (en) Expression vectors
GB2218453B (en) "method of construction."
GB8713609D0 (en) Collapsible structures
GB8623131D0 (en) Motional feedback system
AU4408889A (en) H. saimiri-htlv-x region vector
GB2198764B (en) Ring beam.
Clemm ODIN--An Extensible Software Environment; CU-CS-262-84
AU7998987A (en) Yeast vectors
EP0316320A4 (fr) Reduction des pertes reproductives.
GB8626615D0 (en) Beams &c
GB2314977B (en) Adaptive nulling
CS474786A1 (en) Zpusob vyroby oxibenzinu obsahujiciho terc.alkylmetyletery
AU561237B3 (en) Collapsible crab trap
CS97686A1 (en) Pripravek pro zkouseni prilnavosti galvanoplasticke . vrstvy
CS711086A1 (en) Opticka soustava uplne symetrickeho objektivu .pro laserovou anemometrii
CS401186A1 (en) Zapojeni pro programovatelne rizeni. cyklu posuvove jednotky dvema pracovnimi stoly

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20070408